首页> 外文期刊>Medical science monitor : >Evaluation of culture, tube agglutination, and PCR methods for the diagnosis of brucellosis in humans.
【24h】

Evaluation of culture, tube agglutination, and PCR methods for the diagnosis of brucellosis in humans.

机译:评估培养,试管凝集和PCR方法诊断人类布鲁氏菌病。

获取原文
           

摘要

Background: Brucellosis is prevalent in Saudi Arabia and Brucella melitensisis a leading cause of zoonosis worldwide. Therefore, accurate diagnosis of brucellosis is a key to itstreatment and control. Material/Methods: Twenty patients presented with symptoms of brucellosis wereexamined before and after antibiotic treatment for the diagnosis of brucellosis. Sequential blood samplescollected monthly from each patient were tested for the diagnosis of brucellosis by serum plate agglutinationtest (SPA), standard tube agglutination test (STA), culture, and polymerase chain reaction (PCR). Results:While most of the samples were positive by the agglutination tests, only 40% and 70% were positive byculture and PCR, respectively. After the course of antibiotic treatment, the culture rate and PCR resultswere positive in 10% of the samples. In contrast, anti-brucella antibodies of the treated patients werepositive in 20% and 45% by STA and SPA tests, respectively. Furthermore, agglutinating antibodies inthe presence of 2-mercaptoethanol were positive in 60% of the enrolled patients and negative in all patientsafter the antibiotic treatment. Conclusions: The present study revealed that the expression of anti-brucellaantibodies does not correlate with the status of the disease condition. Further, completion of antibiotictherapy hampered the appearance of brucella-specific IgM antibodies, but did not eliminate the appearanceof residual IgG antibodies in the treated patients. Therefore, for effective therapy, detection of theBrucella organisms by PCR or culture is an important attribute in the evaluation of the treatment regimenagainst brucellosis.
机译:背景:布氏杆菌病在沙特阿拉伯很普遍,而布鲁氏菌是全世界人畜共患病的主要原因。因此,准确诊断布鲁氏菌病是对其治疗和控制的关键。材料/方法:对20名出现布鲁氏菌病症状的患者在抗生素治疗前后进行检查,以诊断布鲁氏菌病。通过血清平板凝集试验(SPA),标准试管凝集试验(STA),培养和聚合酶链反应(PCR)对每个患者每月采集的顺序血样进行诊断,以诊断布鲁氏菌病。结果:虽然凝集试验显示大多数样品均为阳性,但培养和PCR分别只有40%和70%为阳性。经过抗生素处理后,10%的样品的培养率和PCR结果均为阳性。相反,通过STA和SPA测试,所治疗患者的抗小球藻抗体分别为20%和45%阳性。此外,在接受2-巯基乙醇存在的情况下,接受抗生素治疗后的凝集抗体阳性率为60%,所有患者均为阴性。结论:本研究表明抗小球藻抗体的表达与疾病状况无关。此外,抗生素治疗的完成阻碍了布鲁氏菌特异性IgM抗体的出现,但并未消除治疗患者中残留IgG抗体的出现。因此,对于有效的治疗,通过PCR或培养物检测布鲁氏菌属是评估布鲁氏菌病治疗方案的重要属性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号